However, current evidence has implicated the circulating β2M in blood pressure regulation [29], and β2M excretion above 300 μg/g creatinine is indicative of an increased risk of hypertension and severe kidney pathologies, such as rapid kidney functional deterioration and nephron loss for any reason [30,31,32]. This evidence concerns the gene B2M and Hypertension.